BiondVax Leveraging Competencies to Bring ... - Digital Journal
| BVXVDelisted Stock | USD 1.35 0.03 2.17% |
Slightly above 61% of BiondVax Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in BiondVax Pharmaceuticals suggests that many traders are alarmed regarding BiondVax Pharmaceuticals' prospects. BiondVax Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, BiondVax Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
BiondVax |
BiondVax Leveraging Competencies to Bring ... Digital Journal
Read at news.google.com
 |
BiondVax Pharmaceuticals Fundamental Analysis
We analyze BiondVax Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiondVax Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BiondVax Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
BiondVax Pharmaceuticals is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
BiondVax Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BiondVax Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of BiondVax Pharmaceuticals could also be used in its relative valuation, which is a method of valuing BiondVax Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
BiondVax Pharmaceuticals Related Equities
| ADTX | Aditxt | 5.56 | ||||
| GOVX | GeoVax Labs | 4.68 | ||||
| ARMP | Armata Pharmaceuticals | 4.46 | ||||
| ANTX | AN2 Therapeutics | 4.35 | ||||
| ATXI | Avenue Therapeutics | 4.30 | ||||
| CANF | Can Fite | 3.95 | ||||
| SABS | SAB Biotherapeutics | 1.95 | ||||
| SLRX | Salarius Pharmaceuticals | 0.60 | ||||
| ORMP | Oramed Pharmaceuticals | 0.42 | ||||
| MOLN | Molecular Partners | 0.19 | ||||
| PHVS | Pharvaris | 0.36 | ||||
| MLYS | Mineralys Therapeutics, | 0.39 | ||||
| MDWD | Mediwound | 0.73 | ||||
| VCNX | Vaccinex | 0.91 | ||||
| KTTA | Pasithea Therapeutics | 2.15 | ||||
| ADIL | Adial Pharmaceuticals | 2.86 | ||||
| RVPH | Reviva Pharmaceuticals | 3.23 | ||||
| BLRX | BioLineRx | 4.35 | ||||
| RNAZ | Transcode Therapeutics | 5.66 | ||||
| SRZN | Surrozen | 5.95 | ||||
| PEPG | PepGen | 8.41 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in BiondVax Stock
If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |